Emma is an adult medical oncologist having completed her specialist qualification (FRACP) in 2022. Prior to this, she completed her medical studies (Bachelor of Medical Science and Doctor of Medicine) at the University of New South Wales in 2013. She joined CMRI and the ProCan team in 2021. She is currently pursuing a PhD through the University of Sydney. This project is focused on the clinical translation of proteomics technologies to the cancer clinic with the ultimate goal of improving patient outcomes.